By Stephen Buxser, Ph.D. Nerac Analyst
Originally Published: July 21, 2014
A revolution is well underway in the development and application of new nucleic acid sequencing technologies. New techniques have been developed that have profoundly increased the rate at which whole genomes and nearly any other form of DNA or RNA can be rapidly and accurately sequenced. This has opened vast new opportunities for medicine at multiple levels and for basic and applied biology, as well.
Similar to past revolutionary technologies, including cloning techniques in earlier forms, monoclonal antibodies, and high-throughput procedures of many types, unprecedented advances appear to be on the horizon or in many cases are being applied. Beginning with a description in broad outline of previous sequencing techniques, the description below progresses to a brief outline of the Next Generation Sequencing (NGS) techniques that are well worth watching for their increasing effects on how we practice and even how we think about medicine and biology at all levels.
- 77By Stephen Buxser, Ph.D. Originally Published: July 15, 2014 Introduction A major, if not the major, driver of advances in medicine is the development of better diagnostics. The ability to diagnose disease is required before new therapies can be developed or, in many cases, even conceived. Of course the foundation for diagnostics is solid basic…
- 34XcellR8 welcomes Ben Grosse, MXERS Technologies LLC Read the full release here.
- 31By John Leavitt, Ph.D. Nerac Analyst Originally Published: July 21, 2014 When I saw an obit for Hilary Koprowski recently, I was surprised that it did not mention his benchmark work with “monoclonal antibodies” or “hybridomas.” Then I searched Google and found other pages that didn’t mention “monoclonal antibodies” or “hybridomas.” I found some websites that…